160 related articles for article (PubMed ID: 759126)
1. The comparative efficacy of betamethasone dipropionate cream and ointment formulations in the treatment of psoriasis.
Leer JA
Cutis; 1979 Jan; 23(1):97-101. PubMed ID: 759126
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of a betamethasone dipropionate topical glycol preparation in the management of severe psoriasis.
Leer JA
Clin Ther; 1980; 3(3):156-67. PubMed ID: 7006810
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
Kragballe K; Noerrelund KL; Lui H; Ortonne JP; Wozel G; Uurasmaa T; Fleming C; Estebaranz JL; Hanssen LI; Persson LM
Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
[TBL] [Abstract][Full Text] [Related]
4. Real-life effectiveness of once-daily calcipotriol and betamethasone dipropionate gel vs. ointment formulations in psoriasis vulgaris: 4- and 12-week interim results from the PRO-long study.
Lambert J; Hol CW; Vink J
J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1723-31. PubMed ID: 24533503
[TBL] [Abstract][Full Text] [Related]
5. Comparison of fluticasone propionate ointment, 0.005%, and betamethasone-17,21-dipropionate ointment, 0.05%, in the treatment of psoriasis.
Roberts DT
Cutis; 1996 Feb; 57(2 Suppl):27-31. PubMed ID: 8646866
[TBL] [Abstract][Full Text] [Related]
6. Betamethasone dipropionate cream for the treatment of psoriasis. A collaborative evaluation.
Charney P
Arch Dermatol; 1976 May; 112(5):681-3. PubMed ID: 776090
[TBL] [Abstract][Full Text] [Related]
7. A comparison of clobetasol propionate 0.05 percent ointment and an optimized betamethasone dipropionate 0.05 percent ointment in the treatment of psoriasis.
Jacobson C; Cornell RC; Savin RC
Cutis; 1986 Mar; 37(3):213-4, 216, 218-20. PubMed ID: 3514155
[TBL] [Abstract][Full Text] [Related]
8. Calcitriol shows greater persistence of treatment effect than betamethasone dipropionate in topical psoriasis therapy.
Camarasa JM; Ortonne JP; Dubertret L
J Dermatolog Treat; 2003 Jan; 14(1):8-13. PubMed ID: 12745849
[TBL] [Abstract][Full Text] [Related]
9. A double-blind, multicenter comparison between 0.05% halobetasol propionate ointment and 0.05% betamethasone dipropionate ointment in chronic plaque psoriasis.
Mensing H; Korsukewitz G; Yawalkar S
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1149-52. PubMed ID: 1757606
[TBL] [Abstract][Full Text] [Related]
10. A controlled clinical trial of a new formulation of betamethasone dipropionate cream in once-daily treatment of psoriasis.
Ellis CN; Katz HI; Rex IH; Shavin JS; Van Scott EJ; VanderPloeg D
Clin Ther; 1989; 11(6):768-74. PubMed ID: 2692821
[TBL] [Abstract][Full Text] [Related]
11. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.
Kircik LH
J Drugs Dermatol; 2011 Aug; 10(8):878-82. PubMed ID: 21818509
[TBL] [Abstract][Full Text] [Related]
12. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
[TBL] [Abstract][Full Text] [Related]
13. Short- and long-term safety assessment of a two-compound ointment containing calcipotriene/betamethasone dipropionate (Taclonex/Daivobet/Dovobet ointment): hypothalamic-pituitary-adrenal axis function in patients with psoriasis vulgaris.
Fleming C; Ganslandt C; Leese GP
J Drugs Dermatol; 2010 Aug; 9(8):969-74. PubMed ID: 20684147
[TBL] [Abstract][Full Text] [Related]
14. Treatment of nail psoriasis with a two-compound formulation of calcipotriol plus betamethasone dipropionate ointment.
Rigopoulos D; Gregoriou S; Daniel Iii CR; Belyayeva H; Larios G; Verra P; Stamou C; Kontochristopoulos G; Avgerinou G; Katsambas A
Dermatology; 2009; 218(4):338-41. PubMed ID: 19212110
[TBL] [Abstract][Full Text] [Related]
15. Studies on the efficacy and adrenal effects of Diprolene ointment 0.05 percent and Dermovate ointment 0.05 percent in patients with psoriasis or other resistant dermatoses.
Gip L; Hamfelt A
Cutis; 1984 Feb; 33(2):215-7, 220-2, 224. PubMed ID: 6365474
[TBL] [Abstract][Full Text] [Related]
16. The separate daily application of tacalcitol 4 µg/g ointment and budesonide 0.25 mg/g cream is more effective than the single daily application of a two compound ointment containing calcipotriol 50 µg/g and betamethasone dipropionate 0.5 mg/g.
Calzavara-Pinton P; Rossi MT; Sala R; Venturini M
G Ital Dermatol Venereol; 2011 Aug; 146(4):295-9. PubMed ID: 21785396
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and local safety of a calcipotriol/ betamethasone dipropionate ointment in elderly patients with psoriasis vulgaris.
Parslew R; Traulsen J
Eur J Dermatol; 2005; 15(1):37-9. PubMed ID: 15701591
[TBL] [Abstract][Full Text] [Related]
18. Diflorasone diacetate ointment 0.05% versus betamethasone dipropionate ointment 0.05% in moderate-severe plaque-type psoriasis.
Shupack JL; Jondreau L; Kenny C; Stiller MJ
Dermatology; 1993; 186(2):129-32. PubMed ID: 8428041
[TBL] [Abstract][Full Text] [Related]
19. Combined treatment with low-dose cyclosporine and calcipotriol/betamethasone dipropionate ointment for moderate-to-severe plaque psoriasis: a randomized controlled open-label study.
Vena GA; Galluccio A; Pezza M; Vestita M; Cassano N
J Dermatolog Treat; 2012 Aug; 23(4):255-60. PubMed ID: 21756153
[TBL] [Abstract][Full Text] [Related]
20. Calcipotriol plus betamethasone dipropionate gel compared with its active components in the same vehicle and the vehicle alone in the treatment of psoriasis vulgaris: a randomised, parallel group, double-blind, exploratory study.
Fleming C; Ganslandt C; Guenther L; Johannesson A; Buckley C; Simon JC; Stegmann H; Vestergaard Tingleff L
Eur J Dermatol; 2010; 20(4):465-71. PubMed ID: 20413372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
